Member Info for Naewise

I suspect RM will be bursting a gut to announce good news ASAP. Who knows. his early Jan. projection may be a tad on the conservative side and he may catch the market napping. Who in their right mind would want to be out at year end. I ask you!

Tend to agree with Brand. Any good news would be seized upon by the weekend press who like to list their tips for the New Year. Week 1 Jan. could therefore start with a blast and apart from a surge in SP, many will be cheered with potential fantastic news on the Covid front.

I should have said fast forward to last 5 minutes or so of programme to view Samba in all its glory!

For those interested in how Samba Ii works it got a good airing on this programme by Dr Hill see link:https://www.bbc.co.uk/iplayer/episode/m0012tzd/royal-institution-christmas-lectures-2021-1-the-invisible-enemy She said that the machine would shortly be distributed to hospital, care homes AND schools so exactly how big a rival is Samba to Nova? They appear to have quite a lead on us in the market place or have they? More than ever shareholders need an update from BOD!!

@DRB83 - I can confirm that one of the lecturers in this interesting programme was indeed Dr Helen Lee who in 2019 was appointed as a judge for the European Inventor Award. In May 2020, she was recognised on The Times' Science Power List because her invention, the diagnostic kit SAMBA II, which has been being repurposed (originally HIV) for use in COVID-19 testing. I think there are 2 more parts to this unusual series fronted by Van Tam. Interestingly the audience seemed to consist almost solely of teenagers

Up 6% as far as I can see.

On BBC4 tonight introduced by Prof Van Tam on make up of viruses featured leading lecturers one of which was a lady with the surname Lee. In addition to LFT and PCR tests she discussed the merits of Multiplex and showed a machine saying these are or soon would be in hospitals. I struggled to see the name on the machine but it looked like Samba or similar.

A fun poll TLW. I am invested in 2, 9 and 52 with 52 being my biggest investment but 9 is still substantial. Will be interesting to see how they work out.

... much more excitement on the SP fluctuation front - must go and lie down. I hear DA is auditioning for Robert Mitchum's old role in 'The Big Sleep'. Wake me up end of January - perhaps he may throw us a few scraps then. Come back GM -- all is forgiven -- life seemed almost exciting then!

... the SP was £8.66 and many LTHs would have been happy bunnies! Oh for a crystal ball to look at SP on Dec 17th 2022. Will we return to the heady heights of £12? I would settle for £8.66 and be gone. Life is too short!

Nebliss+

@Andip85 -- Reason for London coming off worst is that a large % of the population STILL refuse to be vaccinated. Extremely frustrating as friend in his early 60s with a life threatening heart condition has been told there is no chance of an operation because all hands are at the pump dealing with Covid -- presumably many of those will be the anti vax mob! Many lives will be lost due to these selfish people.

Omicron Variant Update: Novacyt Group Assay Performance Email not displaying correctly?
View it in your browser.
Dear
At Novacyt Group, we pride ourselves on the scientific rigour we apply to all aspects of product design. As the COVID-19 pandemic continues to develop, ongoing analysis becomes increasingly crucial. Our state-of-the-art SARS-CoV-2 genomic surveillance programme allows us to monitor the virus closely as it spreads and mutates. We are pleased to report the latest findings for our solutions:
SNPsig® SARS-CoV-2 EscapePLEX can be used to screen SARS-CoV-2 positive samples for the presence of the Omicron variant with >98% confidence.
PathFlow® COVID-19 Rapid Antigen Pro targets the nucleocapsid protein (NP) of the SARS-CoV-2 virus, and therefore unaffected by the mutations associated with Omicron (BA.1 & BA.2), and other Variants of Concern (VoC).
Novacyt’s other main qPCR assays intended for primary SARS-CoV-2 testing are unaffected by the emergence of the Omicron variant.

READ OUR OFFICIAL STATEMENT HERE

US market open soon which may give a boost!

@Ventura1 -- What size of yacht do you envisage when your boat comes in? I am hoping to upgrade from my present little rubber dinghy with one paddle -- may lash out and get an outboard motor!

@WelshFalcon -- Perhaps, but it's an extremely diverse Portfolio. Good luck if yours is all blue!

All my portfolio including another Covid share is in the red with one exception namely SNG - should tell us something!

There are some chronic asthma sufferers on this forum. Winter can be the most difficult time of the year. Cold, dry air and sudden shifts in the weather can irritate airways, causing production of more mucus. It doesn’t always help to stay indoors, as this can lead to an increase in respiratory illnesses like colds and flu. So even if - and it's a BIG 'if', Covid started to wane next year, there are tens of thousands of people probably millions worldwide, whose lives are a misery due to asthma who will welcome relief through SNG with open arms -- SNG is far from a one trick pony - we tend to forget that!

But remember that conference only a few days ago when many important interested parties will be VERY aware of the huge potential benefits of SNG.

The timing of all this could prove extremely advantageous to SNG!